124 related articles for article (PubMed ID: 4341648)
21. The effect of metyrapone on corticotrophin secretion.
Donald RA; Espiner EA; Beaven DW
J Endocrinol; 1972 Mar; 52(3):517-24. PubMed ID: 4336119
[No Abstract] [Full Text] [Related]
22. Plasma corticotrophin levels in primary and secondary adrenocortical insufficiency.
Besser GM; Cullen DR; Irvine WJ; Landon J
J Endocrinol; 1969 Jan; 43(1):x-xi. PubMed ID: 4307041
[No Abstract] [Full Text] [Related]
23. Stimulation tests of human growth hormone secretion by insulin, lysine vasopressin, pyrogen and glucagon.
Ogawa N
Acta Med Okayama; 1974 Jun; 28(3):181-97. PubMed ID: 4280230
[No Abstract] [Full Text] [Related]
24. [Secretion of growth hormone and ACTH in pituitary tumors].
Materazzi F; Rolla M; Tronchetti F
Ann Endocrinol (Paris); 1972; 33(4):344-52. PubMed ID: 4351893
[No Abstract] [Full Text] [Related]
25. [Adrenal cortex function tests].
Pelkonen R
Duodecim; 1975; 91(7):449-60. PubMed ID: 166813
[No Abstract] [Full Text] [Related]
26. Cushing's disease without hypercortisolism.
Dexter RN; Orth DN; Abe K; Nicholson WE; Liddle GW
J Clin Endocrinol Metab; 1970 May; 30(5):573-9. PubMed ID: 4315478
[No Abstract] [Full Text] [Related]
27. Effect of various ACTH preparations and of metyrapone on the secretion of growth hormone in normal subjects and in hypopituitary patients.
Lee PA; Keenan BS; Migeon CJ; Blizzard RM
J Clin Endocrinol Metab; 1973 Sep; 37(3):389-96. PubMed ID: 4361973
[No Abstract] [Full Text] [Related]
28. A sensitive radioimmunoassay for plasma ACTH levels.
Demura H; West CD; Nugent CA; Nakagawa K; Tyler FH
J Clin Endocrinol Metab; 1966 Dec; 26(12):1297-302. PubMed ID: 4289592
[No Abstract] [Full Text] [Related]
29. Biochemical testing of adrenocortical function.
Rosalki SB
Int J Clin Pract; 1998; 52(3):189-91. PubMed ID: 9684436
[TBL] [Abstract][Full Text] [Related]
30. A fundamental defect of adrenocortical control in Cushing's disease.
James VH; Landon J; Wynn V; Greenwood FC
J Endocrinol; 1968 Jan; 40(1):15-28. PubMed ID: 4294723
[No Abstract] [Full Text] [Related]
31. [Patterns of adrenal steroids present in the blood].
Miura K
Nihon Naibunpi Gakkai Zasshi; 1967 Oct; 43(7):545-52. PubMed ID: 4296563
[No Abstract] [Full Text] [Related]
32. Effects of metyrapone and corticotropin infusion on cortisol disappearance rate in man.
Blichert-Toft M; Folke K; Nielsen ML
J Clin Endocrinol Metab; 1972 Jul; 35(1):59-62. PubMed ID: 4338116
[No Abstract] [Full Text] [Related]
33. Effect of hydrocortisone on ACTH, growth hormone, insulin and glucose in the blood of bilaterally adrenalectomized patients.
Kasperlik-Zaluska AA; Migdalska B; Wilczyńska J; Krassowski J
Horm Metab Res; 1980 Dec; 12(12):676-9. PubMed ID: 6259040
[TBL] [Abstract][Full Text] [Related]
34. [Beta M.S.H. -- an artifact? (author's transl) (proceedings)].
Bachelot I; Wolfsen AR; Odell WD
Ann Endocrinol (Paris); 1976; 37(6):453-4. PubMed ID: 193426
[No Abstract] [Full Text] [Related]
35. Effect of naloxone on plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease.
Kasperlik-Załuska A; Jeske W; Migdalska B; Soszyński P; Wiśniewska-Woźniak T
Acta Med Pol; 1986; 27(3-4):131-9. PubMed ID: 2833071
[No Abstract] [Full Text] [Related]
36. [Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
Bricaire H; Leprat J; Luton JP
Presse Med (1893); 1968 Nov; 76(45):2157-60. PubMed ID: 4305257
[No Abstract] [Full Text] [Related]
37. [Pathology of ACTH secretion].
Oliver C; Vague P
Presse Med (1893); 1970 Dec; 78(55):2495-9. PubMed ID: 4322567
[No Abstract] [Full Text] [Related]
38. Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
Mune T; Morita H; Yasuda K; Murayama M; Yamakita N; Miura K
Clin Endocrinol (Oxf); 1993 Mar; 38(3):265-72. PubMed ID: 8384536
[TBL] [Abstract][Full Text] [Related]
39. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
40. Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
Crystal RG; Rose LI; Jagger PI; Lauler DP
J Clin Endocrinol Metab; 1970 Aug; 31(2):199-203. PubMed ID: 4317343
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
